The association between antecedent vancomycin treatment and hospital- acquired vancomycin-resistant enterococci: A meta-analysis

Archives of Internal Medicine

Volumn 159, Issue 20, 1999, Pages 2461-2468

  Carmeli, Yehuda ^a,c,d   Samore, Matthew H ^a,c   Huskins, W Charles ^b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROCOCCUS; GENETIC HETEROGENEITY; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; LENGTH OF STAY; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS INFECTION; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; ODDS RATIO; PUBLISHING; RESEARCH DESIGN; RISK; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0033536921     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.20.2461     Document Type: Article

References (36)

1. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319:157-161.
2. Uttley AHC, Collins CH, Naidoo J, et al. Vancomycin-resistant enterococci. Lancet. 1988;1:57-58.
3. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet. 1993;342:76-79.
4. Karanfill LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol. 1992;13:195-200.
5. Ena J, Dick R. Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA. 1993;269:598-602.
6. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. MMWR Morb Mortal Wkly Rep. 1995;44:1-13.
7. Eliopoulos GM. Vancomycin-resistant enterococci: mechanism and clinical relevance. Infect Dis Clin North Am. 1997;11:851-865.
8. Leclercq R. Enterococci acquire new kinds of resistance. Clin Infect Dis. 1997; 11(supp 1):80S-84S.
9. Murray BE. Vancomycin-resistant enterococci. Am J Med. 1997;102:284-293.
10. Noskin GA. Vancomycin-resistant enterococci: clinical, microbiologic, and epidemiologic features. J Lab Clin Med. 1997;130:14-20.
11. Rice LB, Shlaes DM. Vancomycin resistance in the Enterococcus: relevance in pediatrics. Pediatr Clin North Am. 1995;42:601-618.
12. Shay DK, Goldmann DA, Jarvis WR. Reducing the spread of antimicrobial-resistant microorganisms: control of vancomycin-resistant enterococci, Pediatr Clin North Am. 1995;42:703-716.
13. Boyce JM. Vancomycin-resistant Enterococcus. Infect Dis Clin North Am. 1997; 11:367-384.
14. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother. 1993;37:2311-2317.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177-188.
16. Egger M, Smith GD, Minder C. Bias in meta-analysis detected by simple, graphical test. BMJ. 1997;315:629-634.
17. Begg CB, Mazumar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;10:1088-1099.
18. Anglim AM, Byers KE, Anneski CJ, et al. Risk factors for VRE colonization during an epidemic. Paper presented at: Sixth Annual Meeting of the Society for Healthcare Epidemiology of America; April 21-23, 1996; Washington, DC.
19. Bonten MJ, Hayden MK, Nathan C, et al. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet. 1996; 348:1615-1619.
20. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 1994;32:1148-1153.
21. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993;31:1280-1285.
22. Dembry LM, Uzokwe K, Zervos MJ. Control of endemic glycopeptide-resistant enterococci. Infect Control Hosp Epidemiol. 1996;17:286-292.
23. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995;20:1126-1133.
24. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993;16:750-755.
25. Henning KJ, Delencastre H, Eagan J, et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J. 1996;15:848-854.
26. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med. 1995;123:250-259.
27. Ostrowsky B, Venkataraman L, D'Agata E, et al. Risk factors for colonization with vancomycin-resistant enterococci in intensive care units. Paper presented at: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28-October 1, 1997; Toronto, Ontario.
28. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 1992;13:700-705.
29. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995; 172:993-1000.
30. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 1996,125: 448-456.
31. Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med. 1998; 158:522-527.
32. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis. 1996;23:767-772.
33. Quale J, Landman D, Saurina G, Atwood E, Ditore V, Patel K. Manipulation of hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis. 1996;23:1020-1025.
34. Anglim AM, Klym B, Byers KE, Schied WM, Fart BM. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med. 1997;157:1132-1136.
35. Evers S, Casadwall B, Charles M, Dutka-Malen S, Galimand M, Courvalin P. Evolution of structure and substrate specificity in D-alanine:D-alanine ligases and related enzymes. J Mol Evol. 1996;42:706-712.
36. Van der Auwera R, Pensart N, Korten V, Murray BE, Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis. 1996;173:1129-1136.